CD8A and neoplasm: For patients in this ‘activated group’, the tumor sample always had substantially higher compositions of T follicular helper cells, CD8+ T cells, regulatory T cells, and M1 and M2 macrophages (Figure 3E; Supplementary Figure 11A).